<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>guanfacine</title><link>http://www.unboundmedicine.com/medline/ebm/research/guanfacine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19877974/full_citation/Safety_and_effectiveness_of_coadministration_of_guanfacine_extended_release_and_psychostimulants_in_children_and_adolescents_with_attention_deficit/hyperactivity_disorder_</link><description>Spencer TJ, Greenbaum M, Ginsberg LD, et al. <br/><span class="title">Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of child and adolescent psychopharmacology">J Child Adolesc Psychopharmacol 2009 Oct; 19(5):501-10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19877974/abstract/Safety_and_effectiveness_of_coadministration_of_guanfacine_extended_release_and_psychostimulants_in_children_and_adolescents_with_attention_deficit/hyperactivity_disorder_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19877974/full_citation/Safety_and_effectiveness_of_coadministration_of_guanfacine_extended_release_and_psychostimulants_in_children_and_adolescents_with_attention_deficit/hyperactivity_disorder_">Full Citation</a></description></item><item><title>Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19785972/full_citation/Guanfacine_extended_release_in_the_treatment_of_attention_deficit/hyperactivity_disorder_</link><description>Rostain AL <br/><span class="title">Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder. [Journal Article]</span><br/><span class="source" title="Current psychiatry reports">Curr Psychiatry Rep 2009 Oct; 11(5):339-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19785972/full_citation/Guanfacine_extended_release_in_the_treatment_of_attention_deficit/hyperactivity_disorder_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19785972/Guanfacine_extended_release_in_the_treatment_of_attention_deficit/hyperactivity_disorder_">Find Related Articles</a> </description></item><item><title>Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19733553/full_citation/Mapping_the_central_effects_of_methylphenidate_in_the_rat_using_pharmacological_MRI_BOLD_contrast_</link><description>Easton N, Marshall FH, Marsden CA, et al. <br/><span class="title">Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neuropharmacology">Neuropharmacology 2009 Sep 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19733553/abstract/Mapping_the_central_effects_of_methylphenidate_in_the_rat_using_pharmacological_MRI_BOLD_contrast_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19733553/full_citation/Mapping_the_central_effects_of_methylphenidate_in_the_rat_using_pharmacological_MRI_BOLD_contrast_">Full Citation</a></description></item><item><title>Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19621977/full_citation/Alpha_2_adrenergic_agonists_in_children_with_inattention_hyperactivity_and_impulsiveness_</link><description>Scahill L <br/><span class="title">Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness. [Journal Article]</span><br/><span class="source" title="CNS drugs">CNS Drugs 2009.:43-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19621977/abstract/Alpha_2_adrenergic_agonists_in_children_with_inattention_hyperactivity_and_impulsiveness_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19621977/full_citation/Alpha_2_adrenergic_agonists_in_children_with_inattention_hyperactivity_and_impulsiveness_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19621977/Alpha_2_adrenergic_agonists_in_children_with_inattention_hyperactivity_and_impulsiveness_">Find Related Articles</a> </description></item><item><title>Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19621976/full_citation/Toward_a_new_understanding_of_attention_deficit_hyperactivity_disorder_pathophysiology:_an_important_role_for_prefrontal_cortex_dysfunction_</link><description>Arnsten AF <br/><span class="title">Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. [Journal Article]</span><br/><span class="source" title="CNS drugs">CNS Drugs 2009.:33-41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19621976/abstract/Toward_a_new_understanding_of_attention_deficit_hyperactivity_disorder_pathophysiology:_an_important_role_for_prefrontal_cortex_dysfunction_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19621976/full_citation/Toward_a_new_understanding_of_attention_deficit_hyperactivity_disorder_pathophysiology:_an_important_role_for_prefrontal_cortex_dysfunction_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19621976/Toward_a_new_understanding_of_attention_deficit_hyperactivity_disorder_pathophysiology:_an_important_role_for_prefrontal_cortex_dysfunction_">Find Related Articles</a> </description></item><item><title>Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19621975/full_citation/Efficacy_and_safety_limitations_of_attention_deficit_hyperactivity_disorder_pharmacotherapy_in_children_and_adults_</link><description>Wigal SB <br/><span class="title">Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. [Journal Article]</span><br/><span class="source" title="CNS drugs">CNS Drugs 2009.:21-31.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19621975/abstract/Efficacy_and_safety_limitations_of_attention_deficit_hyperactivity_disorder_pharmacotherapy_in_children_and_adults_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19621975/full_citation/Efficacy_and_safety_limitations_of_attention_deficit_hyperactivity_disorder_pharmacotherapy_in_children_and_adults_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=1172-7047%26amp;volume=23%26amp;issue=%26amp;spage=21">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19621975/Efficacy_and_safety_limitations_of_attention_deficit_hyperactivity_disorder_pharmacotherapy_in_children_and_adults_">Find Related Articles</a> </description></item><item><title>Carbamazepine-induced hyperammonemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19667003/full_citation/Carbamazepine_induced_hyperammonemia_</link><description>Adams EN, Marks A, Lizer MH <br/><span class="title">Carbamazepine-induced hyperammonemia. [Journal Article]</span><br/><span class="source" title="American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists">Am J Health Syst Pharm 2009 Aug 15; 66(16):1468-70.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19667003/abstract/Carbamazepine_induced_hyperammonemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19667003/full_citation/Carbamazepine_induced_hyperammonemia_">Full Citation</a> | <a href="http://www.ajhp.org/cgi/pmidlookup%3fview=long%26amp;pmid=19667003">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19667003/Carbamazepine_induced_hyperammonemia_">Find Related Articles</a> </description></item><item><title>The neurochemistry of rule use.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19643217/full_citation/The_neurochemistry_of_rule_use_</link><description>Minzenberg MM, Carter CS <br/><span class="title">The neurochemistry of rule use. [Comment, Journal Article]</span><br/><span class="source" title="Biological psychiatry">Biol Psychiatry 2009 Aug 15; 66(4):306.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19643217/full_citation/The_neurochemistry_of_rule_use_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0006-3223(09)00765-3">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19643217/The_neurochemistry_of_rule_use_">Find Related Articles</a> </description></item><item><title>Meta-Analysis: Treatment of Attention-Deficit Hyperactivity Disorder in Children With Comorbid Tic Disorders.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19625978/full_citation/Meta_Analysis:_Treatment_of_Attention_Deficit_Hyperactivity_Disorder_in_Children_With_Comorbid_Tic_Disorders_</link><description>Bloch MH, Panza KE, Landeros-Weisenberger A, et al. <br/><span class="title">Meta-Analysis: Treatment of Attention-Deficit Hyperactivity Disorder in Children With Comorbid Tic Disorders. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the American Academy of Child and Adolescent Psychiatry">J Am Acad Child Adolesc Psychiatry 2009 Jul 21.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19625978/abstract/Meta_Analysis:_Treatment_of_Attention_Deficit_Hyperactivity_Disorder_in_Children_With_Comorbid_Tic_Disorders_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19625978/full_citation/Meta_Analysis:_Treatment_of_Attention_Deficit_Hyperactivity_Disorder_in_Children_With_Comorbid_Tic_Disorders_">Full Citation</a></description></item><item><title>Parallel functional activity profiling reveals valvulopathogens are potent 5-HT2B receptor agonists: implications for drug safety assessment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19570945/full_citation/Parallel_functional_activity_profiling_reveals_valvulopathogens_are_potent_5_HT2B_receptor_agonists:_implications_for_drug_safety_assessment_</link><description>Huang XP, Setola V, Yadav PN, et al. <br/><span class="title">Parallel functional activity profiling reveals valvulopathogens are potent 5-HT2B receptor agonists: implications for drug safety assessment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular pharmacology">Mol Pharmacol 2009 Jul 1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19570945/abstract/Parallel_functional_activity_profiling_reveals_valvulopathogens_are_potent_5_HT2B_receptor_agonists:_implications_for_drug_safety_assessment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19570945/full_citation/Parallel_functional_activity_profiling_reveals_valvulopathogens_are_potent_5_HT2B_receptor_agonists:_implications_for_drug_safety_assessment_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19570945/Parallel_functional_activity_profiling_reveals_valvulopathogens_are_potent_5_HT2B_receptor_agonists:_implications_for_drug_safety_assessment_">Find Related Articles</a> </description></item></channel></rss>